APA (7th ed.) Citation

MHG, K., FS, O., JM, H., SA, A., B, W., R, M., . . . E, O. (2017). Alliance for clinical trials in oncology (ALLIANCE) trial A021501: Preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreas. BMC cancer, 17(1), 505. https://doi.org/10.1186/s12885-017-3441-z

Chicago Style (17th ed.) Citation

MHG, Katz, et al. "Alliance for Clinical Trials in Oncology (ALLIANCE) Trial A021501: Preoperative Extended Chemotherapy Vs. Chemotherapy Plus Hypofractionated Radiation Therapy for Borderline Resectable Adenocarcinoma of the Head of the Pancreas." BMC Cancer 17, no. 1 (2017): 505. https://doi.org/10.1186/s12885-017-3441-z.

MLA (9th ed.) Citation

MHG, Katz, et al. "Alliance for Clinical Trials in Oncology (ALLIANCE) Trial A021501: Preoperative Extended Chemotherapy Vs. Chemotherapy Plus Hypofractionated Radiation Therapy for Borderline Resectable Adenocarcinoma of the Head of the Pancreas." BMC Cancer, vol. 17, no. 1, 2017, p. 505, https://doi.org/10.1186/s12885-017-3441-z.